M347-0171 Screening compound: 2-[2-(4-methyl-1,3-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one

M347-0171 Screening compound: 2-[2-(4-methyl-1,3-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one
M347-0171 Screening compound: 2-[2-(4-methyl-1,3-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound M347-0171
2-[2-(4-methyl-1,3-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M347-0171

Molecular Formula

C19H26N4O3S2 (C19 H26 N4 O3 S2)

Compound Name

2-[2-(4-methyl-1,3-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one

IUPAC name

2-[2-(4-methyl-13-thiazol-2-yl)-4-(piperidine-1-sulfonyl)-1H-pyrrol-1-yl]-1-(pyrrolidin-1-yl)ethan-1-one

SMILES

Cc1csc(-c2cc(S(N3CCCCC3)(=O)=O)cn2CC(N2CCCC2)=O)n1

InChI

InChI=1S/C19H26N4O3S2/c1-15-14-27-19(20-15)17-11-16(28(25,26)23-9-3-2-4-10-23)12-22(17)13-18(24)21-7-5-6-8-21/h11-12,14H,2-10,13H2,1H3

InChI Key

KYERHKNPSDGKLY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27537810

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.214

Distribution Coefficient, logD

2.214

Water Solubility, LogSw

-2.44

Polar Surface Area

59.731

Acid Dissociation Constant (pKa)

23.68

Base Dissociation Constant (pKb)

1.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.90

M347-0171 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with M347-0171 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M347-0171?
Check Price and Availability of M347-0171, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M347-0171 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M347-0171
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M347-0171
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M347-0171 available by request